Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hideshima

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.
Leukemia|August 6, 2013
Histone deacetylase 3 as a novel therapeutic target in multiple myelomaJ Minami, R Suzuki, R Mazitschek, et al.
Leukemia|October 14, 2014
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myelomaR Suzuki, T Hideshima, N Mimura, et al.
Blood|October 26, 2000
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaS P Treon, P Maimonis, D Bua, et al.
Leukemia|September 21, 2007
Biological pathways and in vivo antitumor activity induced by Atiprimod in myelomaP Neri, P Tassone, M Shammas, et al.
Oncogene|January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibitionL Santo, S Vallet, T Hideshima, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Leukemia|December 26, 2001
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsD Gupta, S P Treon, Y Shima, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.
Leukemia|August 6, 2013
Histone deacetylase 3 as a novel therapeutic target in multiple myelomaJ Minami, R Suzuki, R Mazitschek, et al.
Leukemia|October 14, 2014
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myelomaR Suzuki, T Hideshima, N Mimura, et al.
Blood|October 26, 2000
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaS P Treon, P Maimonis, D Bua, et al.
Leukemia|September 21, 2007
Biological pathways and in vivo antitumor activity induced by Atiprimod in myelomaP Neri, P Tassone, M Shammas, et al.
Oncogene|January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibitionL Santo, S Vallet, T Hideshima, et al.
Blood|June 22, 2001
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaF E Davies, N Raje, T Hideshima, et al.
Leukemia|December 26, 2001
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsD Gupta, S P Treon, Y Shima, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Pageof 9